Evidence map›Paper›PMID 26515332›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

KRAS polymorphisms are associated with survival of CRC in Chinese population.

Qiong Dai, Hui Lian Wei, Juan Huang, Tie Jun Zhou, Li Chai, Zhi-Hui Yang

Abstract read
PubMed Publisher
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 2 pooled it
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 2 syntheses or guidelines pooled it, 18 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. OncoTargets and therapy · 2019
    Article
  10. Article
  11. KRAS Gene Polymorphisms and their Impact on Breast Cancer Risk in an Iranian PopulationAsian Pacific journal of cancer prevention : APJCP · 2017
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Qiong DaiDepartment of Human Anatomy, Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China.
Hui Lian WeiDepartment of Pathology, The First Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China.
Juan HuangDepartment of Pathology, The First Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China.
Tie Jun ZhouDepartment of Pathology, The First Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China.
Li ChaiDepartment of Pathology, The First Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China.
Zhi-Hui YangDepartment of Pathology, The First Affiliated Hospital of Luzhou Medical College, Luzhou, 646000, Sichuan, People's Republic of China. yzhih73@126.com.
First Affiliated Hospital of Sichuan Medical University · CNSouthwest Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

rs12245, rs12587, rs9266, rs1137282, rs61764370, and rs712 of KRAS oncogene are characterized in the 3'UTR. The study highlights the important role of these polymorphisms playing in the susceptibility, oxaliplatin-based chemotherapy sensitivity, progression, and prognosis of CRC. Improved multiplex ligation detection reaction (iMLDR) technique is used for genotyping. An unconditional logistic regression model was used to estimate the association of certain polymorphism and CRC risk. The Kaplan-Meier method, log-rank test, and Cox regression model were used to evaluate the effects of polymorphisms on survival analysis. Results demonstrated that TT genotype and T allele of rs712 were associated with the increased risk of CRC; the patients with GG genotype and G allele of rs61764370 had a shorter survival and a higher risk of relapse or metastasis of CRC. Our studies supported the conclusions that rs61764370 and rs712 polymorphisms of the KRAS are functional and it may play an important role in the development of CRC and oxaliplatin-based chemotherapy efficiency and prognosis of CRC.

Indexed as

AdenocarcinomaAdultAgedCase-Control StudiesChemotherapy, AdjuvantColorectal NeoplasmsDisease-Free SurvivalFemaleGene FrequencyGenetic Association StudiesGenetic Predisposition to DiseaseHumansKaplan-Meier EstimateMaleMiddle AgedPolymorphism, Single NucleotideKRAS protein, humanProto-Oncogene Proteins p21(ras)Colorectal cancerKRASPolymorphismsSurvival

Identifiers

PMID26515332
OpenAlexW2268629408

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.